Artal Group’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-200,000
| Closed | -$294K | – | 100 |
|
|
2023
Q3 | $294K | Hold |
200,000
| – | – | 0.01% | 89 |
|
|
2023
Q2 | $406K | Hold |
200,000
| – | – | 0.01% | 102 |
|
|
2023
Q1 | $332K | Hold |
200,000
| – | – | 0.02% | 108 |
|
|
2022
Q4 | $700K | Hold |
200,000
| – | – | 0.04% | 108 |
|
|
2022
Q3 | $914K | Hold |
200,000
| – | – | 0.04% | 111 |
|
|
2022
Q2 | $590K | Hold |
200,000
| – | – | 0.03% | 116 |
|
|
2022
Q1 | $880K | Hold |
200,000
| – | – | 0.04% | 124 |
|
|
2021
Q4 | $1.1M | Hold |
200,000
| – | – | 0.03% | 133 |
|
|
2021
Q3 | $1.18M | Hold |
200,000
| – | – | 0.03% | 134 |
|
|
2021
Q2 | $2.18M | Hold |
200,000
| – | – | 0.04% | 130 |
|
|
2021
Q1 | $3.04M | Buy |
+200,000
| New | +$3.04M | 0.05% | 121 |
|